Filing Details

Accession Number:
0001213900-22-018207
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-05 17:00:12
Reporting Period:
2022-04-01
Accepted Time:
2022-04-05 17:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1553643 Relmada Therapeutics Inc. RLMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1117167 J Charles Casamento C/O Relmada Therapeutics, Inc.
2222 Ponce De Leon Blvd, 3Rd Floor
Coral Gables, FL 33134
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-01 19,800 $3.24 19,800 No 4 M Direct
Common Stock Disposition 2022-04-01 3,300 $29.00 16,500 No 4 S Direct
Common Stock Disposition 2022-04-01 3,300 $29.00 13,200 No 4 S Direct
Common Stock Disposition 2022-04-01 3,300 $29.00 9,900 No 4 S Direct
Common Stock Disposition 2022-04-01 3,300 $29.00 6,600 No 4 S Direct
Common Stock Disposition 2022-04-01 3,300 $29.00 3,300 No 4 S Direct
Common Stock Disposition 2022-04-01 3,300 $29.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2022-04-01 19,800 $0.00 19,800 $3.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
77,511 2017-10-20 2027-10-20 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
  2. The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..